Transmarket Holdings’s Amicus Therapeutics FOLD Stock Holding History

Transmarket Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-218,778	Closed	-$3.16M	–	44
2026 Q1	$3.16M	Buy	218,778 +179,584	+458%	+$2.57M	1.69%	14
2025 Q4	$558K	Buy	+39,194	New	+$385K	0.41%	28

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Transmarket Holdings's FOLD Position: Q2 2026 in Review

Transmarket Holdings sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 218,778 shares — an estimated $3.16M sold.

Transmarket Holdings first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $3.16M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Transmarket Holdings reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Transmarket Holdings sold 218,778 Amicus Therapeutics shares in Q2 2026, an estimated $3.16M.
Transmarket Holdings first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Transmarket Holdings's Amicus Therapeutics position peaked at $3.16M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Transmarket Holdings's 13F filing for Q2 2026, filed 21 Jul 2026.